Abstract
Heroin is highly addictive drug that users use in spite of its negative consequences. Many research on drug dependence, persistence and relapse confirmed that there is a relationship between drug addiction and negative mood states. The present review article investigated the relationship between depression, negative mood, and drug abuse. In addition, the article investigated. The relationship between depression, anxiety, and negative mood-induced heroin-seeking behavior. Previous studies pointed out that depression symptoms could be as a result of heroin use, persistence, and relapse and should be considered in the assessment and treatment of heroin addiction. The greater severity attributable to comorbidity suggests that addressing depression and substance use is a complex and poses an increased challenge for treatment, recovery and abstinence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abo Hamza, E. (2018). The impact of group motivational interview on motivation to change among adolescent drug abusers. The International Journal of Humanities & Social Studies, 6(3), 173–190.
Abo Hamza, E., & Moustafa, A. A. (2020). Motivational interview for substance abuse. In A. A. Moustafa (Ed.), Cognitive, clinical, and neural aspects of drug addiction. Amsterdam: Elsevier.
Addington, J., & Duchak, V. (1997). Reasons for substance use in schizophrenia. Acta Psychiatrica Scandinavia, 96, 329–333. https://doi.org/10.1111/j.1600-0447.1997.tb09925.x.
Adinoff, B. (2004). Neurobiologic processes in drug reward and addiction. Harvard Review of Psychiatry, 12(6), 305–320. https://doi.org/10.1080/10673220490910844.
Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., & Mayet, S. (2008). Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification (review). The Cochrane library. Retrieved from http://www.thecochranelibrary.com.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington: American Psychiatric Association.
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987). Cannabis and schizophrenia A longitudinal study of Swedish conscripts. The Lancet, 330(8574), 1483–1486. https://doi.org/10.1016/S0140-6736(87)92620-1.
Anker, J. J., Kushner, M. G., Thuras, P., Menk, J., & Unruh, A. S. (2016). Drinking to cope with negative emotions moderates alcohol use disorder treatment response in patients with co-occurring anxiety disorder. Drug and Alcohol Dependence, 159, 93–100. https://doi.org/10.1016/j.drugalcdep.2015.11.031.
Australian Institute of Health and Welfare (AIHW). (2017). 2013 National Drug Strategy Household Survey. Canberra: AIHW.
Berna, C., Leknes, S., Holmes, E. A., Edwards, R. R., Goodwin, G. M., & Tracey, I. (2010). Induction of depressed mood disrupts emotion regulation neurocircuitry and enhances pain unpleasantness. Biological Psychiatry, 67(11), 1083–1090. https://doi.org/10.1016/j.biopsych.2010.01.014.
Birchwood, M., Mason, R., MacMillan, F., & Healy, J. (1993). Depression, demoralization and control over psychotic illness: A comparison of depressed and non-depressed patients with a chronic psychosis. Psychological Medicine, 23(02), 387–395. https://doi.org/10.1017/S0033291700028488.
Brière, F.N., Rohde, P., Seeley, J. R., Klein, D., & Lewinsohn, P. M. (2014). Comorbidity between major depression and alcohol use disorder from adolescence to adulthood. Comprehensive Psychiatry, 55(3), 526–533. http://dx.doi.org.ezproxy.uws.edu.au/10.1016/j.comppsych.2013.10.007.
Carroll, K. M., Nich, C., & Rounsaville, B. J. (1995). Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. The Journal of Nervous and Mental Disease, 183(4), 251–259.
Chaney, E. F., & Roszell, D. K. (1982). Relapse in opiate addicts: A behavioural analysis. Addictive Behaviors, 7(3), 291–297. https://doi.org/10.1016/0306-4603(82)90058-2.
Childress, A. R., Ehrman, R., Mclellan, A. T., MacRae, J., Natale, M., & O’Brien, C. P. (1994). Can induced moods trigger drug-related responses in opiate abuse patients? Journal of Substance Abuse and Treatment, 11(1), 17–23. https://doi.org/10.1016/0740-5472(94)90060-4.
Comings, D. E., & Blum, K. (2000). Reward deficiency syndrome: Genetic aspects of behavioural disorders. Progress in Brain Research, 126, 325–341. https://doi.org/10.1016/S0079-6123(00)26022-6.
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on alcohol and related conditions. The Journal of Clinical Psychiatry, 67(2), 247–257.
Darke, S., & Ross, J. (2002). Suicide among heroin users: Rates, risk factors and methods. Addiction, 97, 1383–1394. https://doi.org/10.1046/j.1360-0443.2002.00214.x.
Darke, S., Ross, J., Williamson, A., Mills, K. L., Havard, A., & Teesson, M. (2007). Patterns and correlates of attempted suicide by heroin users over a 3-year period: Findings from the Australian treatment outcome study. Drug and Alcohol Dependence, 87, 146–152. https://doi.org/10.1016/j.drugalcdep.2006.08.010.
Darke, S., Mills, K., Teesson, M., Ross, J., Williamson, A., & Havard, A. (2009). Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psychiatry Research, 166(1), 7–14. https://doi.org/10.1016/j.psychres.2007.12.007.
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., … Zamanipoor Najafabadi, A. H. (2019). Opioids and their endocrine effects: A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism, dgz022. https://doi.org/10.1210/clinem/dgz022.
Dean, A. J., Bell, J., Christie, M. J., & Mattick, R. P. (2004). Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence. European Psychiatry, 19, 510–513. Retrieved from https://doi-org.ezproxy.uws.edu.au/10.1016/j.eurpsy.2004.09.002.
Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Hammad, A., Hickman, M., & McLaren, J. (2011). Mortality among regular or dependent users of heroin and other opioid: A systematic review and meta-analysis of cohort studies. Addiction, 106(1), 32–51. https://doi.org/10.1111/j.1360-0443.1010.03140.x.
Dettenborn, L., Muhtz, C., Skoluda, N., Stalder, T., Steudte, S., Hinkelmann, K., et al. (2012). Introducing a novel method to assess cumulative steroid concentrations: increased hair cortisol concentrations over 6 months in medicated patients with depression. Stress, 15, 348–353. https://doi.org/10.3109/10253890.2011.619239.
Dixon, L., Haas, G., Weiden, P., Sweeney, J., & Frances, A. (1990). Acute effects of drug abuse in schizophrenic patients: Clinical observations and patients’ self-reports. Schizophrenia Bulletin, 16(1), 69–79. https://doi.org/10.1903/schbul/16.1.69.
Drake, R. E., & Mueser, K. T. (2000). Psychosocial approaches to dual diagnosis. Schizophrenia Bulletin, 26(1), 105–118. https://doi.org/10.1093/oxfordjournals.schbul.a033429.
Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016). A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. Journal of Addiction Medicine, 10(2), 91–103. https://doi.org/10.1097/ADM.0000000000000193.
Enman, N. M., Zhang, Y., & Unterwald, E. M. (2014). Connecting the pathology of posttraumatic stress and substance use disorders: Monoamines and neuropeptides. Pharmacology Biochemistry and Behavior, 117, 61–69. https://doi.org/10.1016/j.pbb.2013.12.001.
Falk, D. E., Yi, H. y., & Hilton, M. E. (2008). Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders. Drug and Alcohol Dependence, 94(1–3), 234–245. https://doi.org/10.1016/j.drugalcdep.2007.11.022.
Field, M., & Quigley, M. (2009). Mild stress increases attentional bias in social drinkers who drink to cope: A replication and extension. Experimental and Clinical Psychopharmacology, 17(5), 312–319. https://doi.org/10.1037/a0017090.
Foreman, L. M., Baetu, I., Rego, J., Collins-Praino, L. E., & Moustafa, A. A. (2020). Theories of compulsive drug use: A brief overview of learning and motivation processes. In A. A. Moustafa (Ed.), Cognitive, clinical, and neural aspects of drug addiction. Amsterdam: Elsevier.
Foster, T., Gillespie, K., McClelland, R., & Patterson, C. (1999). Risk factors for suicide independent of DSM-III-R Axis I disorder. Case-control psychological autopsy study in Northern Ireland. The British Journal of Psychiatry, 175(2), 175-179. Retrieved from http://ovidsp.tx.ovid.com.ezproxy.uws.edu.au/sp3.25.0a/ovidweb.cgi?QS2=434f4e1a73d37e8c6ebb.
Gao, W., Zhong, P., Xie, Q., Wang, H., Jin, J., Deng, H., & Lu, Z. (2014). Temporal features of elevated hair cortisol among earthquake survivors. Psychophysiology, 51(4), 319–326. https://doi.org/10.1111/psyp.12179.
Garami, J., Valikhani, A., Parkes, D., Mahlberg, J., Haber, P., Misiak, B., Frydecka, D., & Moustafa, A. A. (2019). Examining perceived stress, childhood trauma and interpersonal trauma in individuals with drug addiction. Psychological Reports, 122, 433–450.
Gardner, E. L. (2011). Addiction and brain reward and antireward pathways. Advances in Psychosomatic Medicine, 30, 22–60. https://doi.org/10.1159/000324065.
Gardner, E. L., & Ashby, C. R. (2000). Heterogeneity of the mesotelencephalic dopamine fibers: Physiology and pharmacology. Neuroscience and Biobehavioral Reviews, 24(1), 115–118. https://doi.org/10.1016/S0149-7634(99)00048-2.
Gold, P. W. (2015). The organization of the stress system and its dysregulation in depressive illness. Molecular Psychiatry, 20(1), 32–47. https://doi.org/10.1038/mp.2014.163.
Goldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014). Prevalence of axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses. Addictive Behaviors, 39(3), 520–531. https://doi.org/10.1016/j.addbeh.2013.11.022.
Goodwin, R. D., Stayner, D. A., Chinman, M. J., Wu, P., Tebes, J. K., & Davidson, L. (2002). The relationship between anxiety and substance use disorders among individuals with severe affective disorders. Comprehensive Psychiatry, 43(4), 245–252. https://doi.org/10.1053/comp.2002.33500.
Grant, B. F. (1996). DSM-IV, DSM-III-R, and ICD-10 alcohol and drug abuse/harmful use and dependence, United States, 1992: A nosological comparison. Alcoholism: Clinical and Experimental Research, 20(8), 1481–1488. https://doi.org/10.1111/j.1530-0277.1996.tb01152.x.
Hankin, B. L. (2006). Adolescent depression: Description, causes, and interventions. Epilepsy and Behavior., 8, 102–114. https://doi.org/10.1016/j.yebeh.2005.10.012.
Hardy, L., & Hogarth, L. (2017). A novel concurrent pictorial choice model of mood-induced relapse in hazardous drinkers. Experimental and Clinical Psychopharmacology, 25(6), 448–455. https://doi.org/10.1037/pha0000155.
Hasin, D. S., Wei-Yuan, T., Endicott, J., Mueller, T. I., Coryell, W., & Keller, M. (1996). Five-year course of major depression: Effects of comorbid alcoholism. Journal of Affective Disorders, 41(1), 63–70. https://doi.org/10.1016/0165-0327(96)00068-7.
Hasin, D., Liu, X., Nunes, E., McCloud, S., Samet, S., & Endicott, J. (2002). Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry, 59(4), 375–380. https://doi.org/10.1001/archpsyc.59.4.375.
Havard, A., Teesson, M., Darke, S., & Ross, J. (2006). Depression among heroin users: 12-month outcomes from the Australian treatment outcome study (ATOS). Journal of Substance Abuse Treatment, 30(4), 355–362. https://doi.org/10.1016/j.jsat.2006.03.012.
Hickie, I. B., Koschera, A., Davenport, T. A., Naismith, S. L., & Scott, E. M. (2001). Comorbidity of common mental disorders and alcohol or other substance misuse in Australian general practice. The Medical Journal of Australia, 175, S31-36. Retrieved from http://europepmc.org/abstract/med/11556433.
Hogarth, L. (2020). Addiction is driven by excessive goal-directed drug choice under negative affect: translational critique of habit and compulsion theory. Neuropsychopharmacology., 45, 720–735.
Hogarth, L., Balleine, B. W., Corbit, L. H., & Killcross, S. (2013). Associative learning mechanisms underpinning the transition from recreational drug use to addiction. Annals of the New York Academy of Sciences, 1282(1), 12–24. https://doi.org/10.1111/j.1749-6632.2012.06768.x.
Hogarth, L., He, Z., Chase, H. W., Wills, A. J., Troisi, J., Leventhal, A. M., Mathew, A. R., & Hitsman, B. (2015). Negative mood reverses devaluation of goal-directed drug-seeking favouring an incentive learning account of drug dependence. Psychopharmacology, 232(17), 3235–3247. https://doi.org/10.1007/s00213-015-3977-z.
Hogarth, L., Mathew, A. R., & Hitsman, B. (2017). Current major depression is associated with greater sensitivity to the motivational effect of both negative mood induction and abstinence on tobacco-seeking behavior. Drug and Alcohol Dependence, 176, 1–6. https://doi.org/10.1016/j.drugalcdep.2017.02.009.
Hogarth, L., Hardy, L., Mathew, A. R., & Hitsman, B. (2018). Negative mood-induced alcohol-seeking is greater in young adults who report depression symptoms, drinking to cope, and subjective reactivity. Experimental and Clinical Psychopharmacology, 26(2), 138–146. https://doi.org/10.1037/pha0000177.
Hogarth, L., Hardy, L., Bakou, A., Mahlberg, J., Weidemann, G., Cashel, S., & Moustafa, A. A. (2019). Negative mood induction increases choice of heroin versus food pictures in opiate-dependent individuals: Correlation with self-medication coping motives and subjective reactivity. Frontiers in Psychiatry, 10. https://doi.org/10.3389/fpsyt.2019.00274
Hursh, S. R., & Silberberg, A. (2008). Economic demand and essential value. Psychological Review, 115(1), 186–198. https://doi.org/10.1037/0033-295X.115.1.186.
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006). Neural mechanisms of addiction: The role of reward-related learning and memory. Annual Review of Neuroscience, 29, 565–598. https://doi.org/10.1146/annurev.neuro.29.051605.113009.
Ibabe, I., Stein, J. A., Nyamathi, A., & Bentler, P. M. (2014). Predictors of substance abuse treatment participation among homeless adults. Journal of Substance Abuse Treatment, 46, 374–381. https://doi.org/10.1016/j.sat.2013.10.008.
Ikemoto, S. (2010). Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory. Neuroscience & Biobehavioral Reviews, 35(2), 129–150. https://doi.org/10.1016/j.neubiorev.2010.02.001.
Juruena, M. F., Bocharova, M., Agustini, B., & Young, A. H. (2018). Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review. Journal of Affective Disorders, 233, 45–67. https://doi.org/10.1016/j.jad.2017.09.052.
Kalivas, P. (2009). The glutamate homeostasis hypothesis of addiction. Nature Reviews Neuroscience, 10, 561–572. https://doi.org/10.1038/nrn25159.
Karpyak, V. M., Biernacka, J. M., Geske, J. R., Abulseoud, O. A., Brunner, M. D., Chauhan, M., & Mrazek, D. A. (2016). Gender-specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional states. Addiction, 111(8), 1366–1375. https://doi.org/10.1111/add.13386.
Kazour, F., Soufia, M., Rohayem, J., & Richa, S. (2016). Suicide Risk of Heroin Dependent Subjects in Lebanon. Community Mental Health Journal, 52(5), 589–596. https://doi.org/10.1007/s10597-015-9952-7.
Kenny, P. J., Chen, S. A., Kitamura, O., Markou, A., & Koob, G. F. (2006). Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. Journal of Neuroscience, 26(22), 5894–5900. https://doi.org/10.1523/JNEUROSCI.0740-06.2006.
Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., Wittchen, H., & Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the national comorbidity survey. Archives of General Psychiatry, 51(1), 8–19. https://doi.org/10.1001/archpsyc.1994.03950010008002.
Khantzian, E. J. (1985). The self medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. American Journal of Psychiatry, 142(11), 1259–1264. https://doi.org/10.1007/978-1-4613-1837-8_7.
Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231-244. Retrieved from http://ovidsp.tx.ovid.com.ezproxy.uws.edu.au/sp-3.25.0a/ovidweb.cgi?WebLinkFrameset.
Khantzian, E. J., Mack, J. E., & Schatzberg, A. F. (1974). Heroin use as an attempt to cope: Clinical observations. American Journal of Psychiatry, 131(2), 160–164. Retrieved from http://ajp.psychiatryonline.org.ezproxy.uws.edu.au.
Kilpatrick, D. G., Acierno, R., Saunders, B., Resnick, H. S., Best, C. L., & Schnurr, P. P. (2000). Risk factors for adolescent substance abuse and dependence. Journal of Consulting and Clinical Psychology, 68(1), 19–30 Retrieved from http://dx.doi.org.ezproxy.uws.edu.au/10.1037/0022-006X.68.1.19.
Koob, G. F. (2013). Addiction is a reward deficit and stress surfeit disorder. Frontiers in Psychiatry, 4, 72. http://doi.org.ezproxy.uws.edu.au/10.3389/fpsyt.2013.00072036384.
Koob, G. F., & Le Moal, M. (2001). Drug addiction, Dysregulation of reward, and Allostasis. Neuropsychopharmacology, 24(2), 97–129. https://doi.org/10.1016/S0893-133X(00)00195-0.
Kosten, T. R., Markou, A., & Koob, G. F. (1998). Depression and stimulant dependence: Neurobiology and pharmacotherapy. The Journal of Nervous and Mental Disease, 186(12), 737–745. Retrieved from http://ovidsp.tx.ovid.com.ezproxy.uws.edu.au/sp-3.25.0a/ovidweb.cgi?
Kunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., Yuuki, N., Otsubo, T., Oshima, A., Kudo, K., Inoue, T., Kitaichi, Y., Shirakawa, O., Isogawa, K., Nagayama, H., Kamijima, K., Nanko, S., Kanba, S., Higuchi, T., & Mikuni, M. (2006). Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: A multicenter study. Neuropsychopharmacology, 31(1), 212–220. https://doi.org/10.1038/sj.npp.1300868.
Kushner, M. G., Abrams, K., Thuras, P., Hanson, K. L., Brekke, M., & Sletten, S. (2005). Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcoholism: Clinical and Experimental Research, 29(8), 1432–1443. https://doi.org/10.1097/01.alc.0000175072.17623.f8.
Kushner, M. G., Maurer, E. W., Thuras, P., Donahue, C., Frye, B., Menary, K. R., … Van Demark, J. (2013). Hybrid cognitive behavioral therapy versus relaxation training for co-occurring anxiety and alcohol disorder: A randomized clinical trial: Correction to Kushner et al. (2012). Journal of Consulting and Clinical Psychology, 81(3), 442–442. https://doi.org/10.1037/a0031948.
Lalanne, L., Ayranci, G., Kieffer, B. L., & Lutz, P. E. (2014). The kappa opioid receptor: From addiction to depression, and back. Frontiers in Psychiatry, 5, 1–17. https://doi.org/10.3389/fpsyt.2014.00170.
Le Moal, M., & Koob, G. F. (2007). Drug addiction: Pathways to the disease and pathophysiological perspectives. European Neuropsychopharmacology, 17(6), 377–393. https://doi.org/10.1016/j.euroneuro.2006.10.006.
Lee, K. H., & Yen, C. F. (2018). The relationships between depression, neuroticism, and attitudes (NDA model) in heroin abusers in Taiwan. American Journal on Addictions, 27(2), 139–143. https://doi.org/10.1111/ajad.12691.
Lee, K.-H., Lin, H.-C., Wang, P.-W., & Yen, C.-F. (2016). An integrated model of depression, compulsion, and mindfulness among heroin abusers in Taiwan. The American Journal on Addictions, 25(3), 227–232. https://doi.org/10.1111/ajad.12365.
Leventhal, A. M., Trujillo, M., Ameringer, K. J., Tidey, J. W., Sussman, S., & Kahler, C. W. (2014). Anhedonia and the relative reward value of drug and nondrug reinforcers in cigarette smokers. Journal of Abnormal Psychology, 123(2), 375–386. https://doi.org/10.1037/a0036384.
Li, Q., Wang, Y., Zhang, Y., Li, W., Yang, W., Zhu, J., Wu, N., Chang, H., Zheng, Y., Qin, W., Zhao, L., Yuan, K., Liu, J., Wang, W., & Tian, J. (2012). Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: An event-related fMRI study. Brain Research, 1469(2), 63–72. https://doi.org/10.1016/j.brainres.2012.06.024.
Liao, Y. T., Chen, C. Y., Ng, M. H., Huang, K. Y., Shao, W. C., Lin, T. Y., Chen, V. C. H., & Gossop, M. (2017). Depression and severity of substance dependence among heroin dependent patients with ADHD symptoms. American Journal on Addictions, 26(1), 26–33. https://doi.org/10.1111/ajad.12487.
Lin, W. C., Chou, K. H., Chen, H. L., Huang, C. C., Lu, C. H., Li, S. H., Wang, Y. L., Cheng, Y. F., Lin, C. P., & Chen, C. C. (2012). Structural deficits in the emotion circuit and cerebellum are associated with depression, anxiety and cognitive dysfunction in methadone maintenance patients: A voxel-based morphometric study. Psychiatry Research - Neuroimaging, 201(2), 89–97. https://doi.org/10.1016/j.pscychresns.2011.05.009.
Litt, M. D., Cooney, N. L., & Kadden, R. M. (1990). Reactivity to alcohol cues and induced moods in alcoholics. Addictive Behaviours, 15(2), 137–146. https://doi.org/10.1016/0306-4603(90)90017-R.
Lynskey, M. T., & Hall, W. (1998). Cohort trends in age of initiation to heroin use. Drug and Alcohol Review, 17(3), 289–297. https://doi.org/10.1080/09595239800187121.
Mahlberg, J., Weidemann, G., Hogarth, L, Moustafa, A. A. (2019). Alcohol cue-reactivity: Concurrent validity of cue-elicited craving and human Pavlovian-to-instrumental transfer. Addiction Research and Therapy.
Maremmani, A. G. I., Cerniglia, L., Cimino, S., Bacciardi, S., Rovai, L., Rugani, F., … Maremmani, I. (2015). Towards a specific psychopathology of heroin addiction. Comparison between heroin use disorder and major depression patients. Heroin Addiction and Related Clinical Problems, 17(6), 9–16.
Marissen, M. A., Franken, I. H., Waters, A. J., Blanken, P., Van Den Brink, W., & Hendriks, V. M. (2006). Attentional bias predicts heroin relapse following treatment. Addiction, 101(9), 1306–1312. https://doi.org/10.1111/j.1360-0443.2006.01498.x.
Mason, B. J., Light, J. M., Escher, T., & Drobes, D. J. (2008). Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics. Psychopharmacology, 200(1), 141–150. https://doi.org/10.1007/s00213-008-1192-x.
Massaly, N., Morón, J. A., & Al-Hasani, R. (2016). A trigger for opioid misuse: Chronic pain and stress dysregulate the mesolimbic pathway and kappa opioid system. Frontiers in Neuroscience, 10(NOV), 1–7. https://doi.org/10.3389/fnins.2016.00480.
Mazei-Robison, M. S., Koo, J. W., Friedman, A. K., Lansink, C. S., Robison, A. J., Vinish, M., Krishnan, V., Kim, S., Siuta, M. A., Galli, A., Niswender, K. D., Appasani, R., Horvath, M. C., Neve, R. L., Worley, P. F., Snyder, S. H., Hurd, Y. L., Cheer, J. F., Han, M. H., Russo, S. J., & Nestler, E. J. (2011). Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron, 72(6), 977–990. https://doi.org/10.1016/j.neuron.2011.10.012.
McIntosh, C., & Ritson, B. (2001). Treating depression complicated by substance misuse. Advances in Psychiatric Treatment, 7(5), 357–364. Retrieved from http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.692.3320&rep=rep1&type=pdf.
McKenna, C., & Ross, C. (1994). Diagnostic conundrums in substance abusers with psychiatric symptoms: Variables suggestive of dual diagnosis. The American Journal of Drug and Alcohol Abuse, 20(4), 397–412. https://doi.org/10.1016/S0011-393X(05)80795-7.
McLellan, A. T., Woody, G. E., & O'Brien, C. P. (1979). Development of psychiatric illness in drug abusers: Possible role of drug preference. New England Journal of Medicine, 301(24), 1310–1314. https://doi.org/10.1056/NEJM197912133012403.
Moak, D. H., Anton, R. F., Latham, P. K., Voronin, K. E., Waid, R. L., & Durazo-Arvizu, R. (2003). Sertraline and cognitive behavioural therapy for depressed alcoholics: Results of a placebo-controlled trial. Journal of Clinical Psychopharmacology, 23(6), 553–562. https://doi.org/10.1097/01.jcp.0000095346.32154.41.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., Altman, D., Antes, G., et al. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7). https://doi.org/10.1371/journal.pmed.1000097.
Moustafa, A. A. (2020). Cognitive, clinical, and neural aspects of drug addiction. Amsterdam: Elsevier.
Moustafa, A. A., Parkes, D., Fitzgerald, L., Underhill, D., Garami, J., Levy-Gigi, E., Stramecki, F., Valikhani, A., Frydecka, D., & Misiak, B. (2018). The Relationship between Childhood Trauma, Early-life Stress, and Alcohol and Drug Use, Abuse, and Addiction: An Integrative Review. Current Psychology.
Moustafa, A. A., Garami, J., Solieman, A., Eissa, A. M., & Shakir, M. (2020). Causes and clinical characteristics of drug abuse. In A. A. Moustafa (Ed.), Cognitive, clinical, and neural aspects of drug addiction. Amsterdam: Elsevier.
Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: A review of etiological theories. Addictive Behaviours, 23(6), 717–734. https://doi.org/10.1016/S0306-4603(98)00073-2.
Murphy, A., Taylor, E., & Elliott, R. (2012). The detrimental effects of emotional process dysregulation on decision-making in substance dependence. Frontiers in Integrative Neuroscience, 6(101), 1–24. https://doi.org/10.3389/fnint.2012.00101.
Nestler, E. J. (2013). Cellular basis of memory for addiction. Dialogues in Clinical Neuroscience, 15(4), 431–443.
Nestler, E. J., & Carlezon, W. A. (2006). The mesolimbic dopamine reward circuit in depression. Biological Psychiatry, 59(12), 1151–1159. https://doi.org/10.1016/j.biopsych.2005.09.018.
Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. Jama, 291(15), 1887–1896. Retrieved from http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/jama/4924/.
Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation of Septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology, 47(6), 419–427. https://doi.org/10.1037/h0058775.
Otto, M. W., Powers, M. B., & Fischmann, D. (2005). Emotional exposure in the treatment of substance use disorders: Conceptual model, evidence, and future directions. Clinical Psychology Review, 25(6), 824–839. https://doi.org/10.1016/j.cpr.2005.05.002.
Penick, E. C., Powell, B. J., Nickel, E. J., Bingham, S. F., Riesenmy, K. R., Read, M. R., & Campbell, J. (1994). Co-morbidity of lifetime psychiatric disorder among male alcoholic patients. Alcoholism Clinical and Experimental Research, 18(6), 1289–1293. https://doi.org/10.1111/j.1530-0277.1994.tb01425.x.
Penington Institute. (2018). Saving lives: Australian naloxone access model. Melbourne: Penington Institute.
Regier, D. A., Farmer, M. E., Rae, D. S., & Goodwin, F. K. (1990). Comorbidity of mental –disorders with alcohol and other drug abuse-results from the epidemiologic catchment area (ECA) study. The Journal of the American Medical Association, 264(19), 2511–2518. https://doi.org/10.1001/jama.1990.03450190043026.
Renoir, T., Pang, T. Y., & Lanfumey, L. (2012). Drug withdrawal-induced depression: Serotonergic and plasticity changes in animal models. Neuroscience and Biobehavioral Reviews, 36(1), 696–726. https://doi.org/10.1016/j.neubiorev.2011.10.003.
Ridgely, M. S., Goldman, H. H., & Willenbring, M. (1990). Barriers to the care of persons with dual diagnoses: Organisational and financing issues. Schizophrenia Bulletin, 16(1), 123–132. https://doi.org/10.1093/schbul/16.1.123.
Robbins, S. J., Ehrman, R. N., Childress, A. R., Cornish, J. W., & O’Brien, C. P. (2000). Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug and Alcohol Dependence, 59(1), 33–42. https://doi.org/10.1016/S0376-8716(99)00103-9.
Robinson, T. E., & Berridge, K. C. (2003). Parsing reward. Trends in Neurosciences, 26(9), 507–513. https://doi.org/10.1016/S0166-2236(03)00233-9.
Rounsaville, B. J., Weissman, M. M., Crits-Christoph, K., Wilber, C., & Kleber, H. (1982). Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome. Archives of General Psychiatry, 39(2), 151–156. https://doi.org/10.1001/archpsyc.1982.04290020021004.
Roxburgh, A., Hall, W. D., Dobbins, T., Gisev, N., Burns, L., Pearson, S., & Degenhardt, L. (2017). Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug and Alcohol Dependence, 179, 291–298. https://doi.org/10.1016/j.drugalcdep.2017.07.018.
Ruffle, J. K. (2014). Molecular neurobiology of addiction: What’s all the (Δ)FosB about? American Journal of Drug and Alcohol Abuse, 40(6), 428–437. https://doi.org/10.3109/00952990.2014.933840.
Russo, S., & Nestler, E. J. (2013). The brain reward circuitry in mood disorders. Nature Reviews Neuroscience, 14(9), 1–34. https://doi.org/10.1038/jid.2014.371.
Salamone, J. D., Cousins, M. S., & Bucher, S. (1994). Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behavioural Brain Research, 65(2), 221–229. https://doi.org/10.1016/0166-4328(94)90108-2.
Saleme, D., & Moustafa, A. A. (2020). The multifaceted nature of risk-taking in drug addiction. In A. A. Moustafa (Ed.), Cognitive, clinical, and neural aspects of drug addiction. Amsterdam: Elsevier.
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology, 33(2), 368–377. https://doi.org/10.1038/sj.npp.1301408.
Seifert CL, Magon S, Sprenger T, Lang UE, Huber CG, et al. (2015). Reduced volume of the nucleus accumbens in heroin addiction. European archives of psychiatry and clinical neuroscience, 265, 637–45.
Shi, J., Li, S. X., Zhang, X. L., Wang, X., Foll, B. Le, Zhang, X. Y., … Lu, L. (2009). Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts. American Journal of Drug and Alcohol Abuse, 35(5), 267–272. https://doi.org/10.1080/00952990902933878.
Sordo, L., Chahua, M., Bravo, M. J., Barrio, G., Brugal, M. T., Domingo-Salvany, A., … De la Fuente, L. (2012). Depression among regular heroin users: The influence of gender. Addictive Behaviors, 37(1), 148–152. https://doi.org/10.1016/j.addbeh.2011.09.009.
Steudte, S., Stalder, T., Dettenborn, L., Klumbies, E., Foley, P., Beesdo-Baum, K., & Kirschbaum, C. (2011). Decreased hair cortisol concentrations in generalised anxiety disorder. Psychiatry research, 186(2–3), 310–314. https://doi.org/10.1016/j.psychres.2010.09.002.
Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K. R., Sampson, N., & Kessler, R. C. (2010). Mental disorders as risk factors for substance use, abuse and dependence: Results from the 10-year follow-up of the national comorbidity survey. Addiction, 105, 1117–1128. https://doi.org/10.1111/j.1360-0443.2010.02902.x.
Teesson, M., Havard, A., Fiarbairn, S., Ross, J., Lynskey, M., & Darke, S. (2005). Depression among entrants to treatment for heroin dependence in the Australian treatment outcome study (ATOS): Prevalence, correlates and treatment seeking. Drug and Alcohol Dependence, 78, 309–315. https://doi.org/10.1016/j.drugalcdep.2004.12.001.
Teesson, M., Marel, C., Darke, S., Ross, J., Slade, T., Burns, L., Lynskey, M., Memedovic, S., White, J., & Mills, K. L. (2015). Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian treatment outcome study. Addiction, 110(6), 986–993. https://doi.org/10.1111/add.12860.
Tindle, R., Ghafar, F., Moustafa, A. A., Abo Hamza, E. (2020). The interrelationship between alcoholism, depression, and anxiety. The nature of Depression. Elsevier.
Torrens, M., Rossi, P. C., Martinez-Riera, R., Martinez-Sanvisens, D., & Bulbena, A. (2012). Psychiatric co-morbidity and substance use disorders: Treatment in parallel systems or in one integrated system. Substance Use and Misuse, 47(8–9), 1005–1014. https://doi.org/10.3109/10826084.2012.663296.
Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010). A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review, 30, 155–166. https://doi.org/10.1016/j.cpr.2009.10.006.
Velten, E. (1968). A laboratory task for induction of mood states. Behaviour Research and Therapy, 6(4), 473–482. https://doi.org/10.1016/0005-7967(68)90028-4.
Wacker, J., Dillon, D. G., & Pizzagalli, D. A. (2009). The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: Integration of resting EEG, fMRI, and volumetric techniques. NeuroImage, 46(1), 327–337. https://doi.org/10.1016/j.neuroimage.2009.01.058.
Walter, M., Bentz, D., Schicktanz, N., Milnik, A., Aerni, A., Gerhards, C., … De Quervain, D. (2015). Effects of cortisol administration on craving in heroin addicts. Translational Psychiatry, 5(7). https://doi.org/10.1038/tp.2015.101.
Wisniewski, A. B., Brown, T. T., John, M., Cofranceso, J., Golub, E. T., Ricketts, E. P., … Dobs, A. S. (2006). Cortisol levels and depression in men and women using heroin and cocaine. Psychoneuroendocrinology, 31(2), 250–255. https://doi.org/10.1016/j.psyneuen.2005.08.002.
Yang, J., Li, J., Xu, G., Zhang, J., Chen, Z., Lu, Z., & Deng, H. (2016). Elevated hair cortisol levels among heroin addicts on current methadone maintenance compared to controls. PLoS One, 11(3), 1–11. https://doi.org/10.1371/journal.pone.015072.
Acknowledgements
AAM obtained funding from Qatar National Research Fund (OSRA).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical Statement
The current research does not require data collection and consent form and it is basically a systematic review.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Moustafa, A.A., Tindle, R., Cashel, S. et al. Bidirectional relationship between heroin addiction and depression: Behavioural and neural studies. Curr Psychol 41, 5195–5211 (2022). https://doi.org/10.1007/s12144-020-01032-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12144-020-01032-4